Abstract
Aim
The aim of this study is to highlight the pitfalls in the diagnosis and management of tuberculosis (TB)-associated uveitis.
Methods
This is a retrospective review of case records of four patients with TB-associated uveitis.
Results
In cases 1 and 2, failure to treat tubercular uveitis with anti-tubercular therapy (ATT) and unopposed steroid therapy led to a serious systemic consequence—development of intra-cranial tuberculoma. In case 4, similar failure to initiate ATT caused recurrent disease (focal choroiditis) in the eye. All four cases showed appearance of new lesions or worsening of existing lesions in the eye, following initiation of ATT. Such paradoxical reactions resolved by adding/increasing corticosteroid therapy.
Conclusion
TB-associated uveitis needs a strong index of suspicion for diagnosis and a combined anti-tubercular plus anti-inflammatory therapy for successful outcome.
Similar content being viewed by others
Introduction
Tuberculosis (TB) accounts for a significant proportion of uveitis cases in endemic areas.1 With the increase in global burden of TB and recognition of newer forms of tubercular uveitis, increasing numbers of patients are likely to be diagnosed of ocular TB.2 However, the diagnosis of tubercular uveitis is often presumptive,3 and its management lacks uniform guidelines. We describe four cases that highlight the pitfalls that may occur in the diagnosis and treatment of TB-associated uveitis.
Case 1
A 38-year-old man was diagnosed for intermediate uveitis in the left eye and was treated with periocular and topical steroids. Anti-tubercular therapy (ATT) was not given though his tuberculin reaction was 16 × 16 mm after 48 h, and other tests were negative. After 7 years, he developed an intra-cranial tuberculoma (Figure 1), for which ATT was initiated. After 5 months of ATT, he complained of reduced vision in the left eye. We detected anterior uveitis in the right eye and recurrent intermediate uveitis in the left eye, which we treated with oral and topical prednisolone while continuing ATT. Vitritis reduced significantly and BCVA improved to 20/60 in left eye after 3 months. The cerebral lesion also regressed completely.
Case 2
A 36-year-old woman, presenting with a solitary choroidal granuloma in the left eye (Figure 2a), was diagnosed as probable ocular sarcoidosis, based on raised serum angiotensin convertase enzyme (SACE) levels, and negative tuberculin test and chest radiography. The lesion regressed well with oral prednisolone (Figure 2b). After 3 months later, computerised tomography revealed intra-cranial space-occupying lesion in her left parietal lobe, diagnosed as intra-cranial tuberculoma (Figure 2c). Tuberculin reaction was now 15 × 15 mm. ATT was started. But 2 weeks later, she developed a chorio-retinitis patch in the left eye, adjacent to the scar of the previous lesion (Figure 2d). The lesion subsided with intravenous methyl prednisolone (IVMP, 1 mg/kg for 3 days) followed by oral prednisolone.
Case 3
A 45-year-old man with decreased vision in the left eye (BCVA: 20/80) for 1 month showed serpiginous choroiditis in the left eye (Figures 3a and b). Tuberculin test was 23 × 24 mm, chest radiography was normal and vitreous biopsy was negative for mycobacterial DNA. We started ATT, adding oral prednisolone (1 mg/kg body weight) after 2 days (Figure 3c). However, after 1 week, BCVA deteriorated to 20/160 in the left eye with clear advancement of choroiditis margins. IVMP (1 mg/kg for 3 days) followed by oral prednisolone led to resolution of lesions.
Case 4
A 24-year-old man presented with extensive pigmentary scarring in the right eye and serpiginous-like choroiditis with focal skip lesions in the left eye (Figures 4a and b). Tuberculin test was 20 × 20 mm at 48 h; chest radiograph was normal. We explained the need for starting ATT, but the patient refused fearing side effects of the medication. We treated with IVMP and oral prednisolone, which caused resolution of serpiginous lesions. However, 4 months later, reactivated lesions of serpiginous choroiditis were seen in the left eye (Figure 4c). Vitreous biopsy detected mycobacterial DNA. The patient agreed for ATT. Oral prednisolone (1 mg/kg body weight) was added after 2 days. But 1 week later, the choroiditis lesions were found enlarged and associated with serous retinal detachment (Figure 4d). IVMP therapy finally caused resolution of all lesions.
Discussion
These case reports illustrate several pitfalls that may occur in diagnosis and management of TB-associated uveitis. In cases 1 and 2, failure to treat tubercular uveititis with ATT (tuberculin reaction was positive in case 1 and false negative in case 2), along with unopposed steroid therapy, led to a serious adverse systemic consequence—intra-cranial tuberculoma. In case 4, non-inclusion of ATT during initial therapy (in spite of strong evidence of latent TB) caused recurrent disease in the eye. False-negative tuberculin reaction could occur in poor nutrition and general health, overwhelming acute illness, immunosuppression, or early stages of infection.4 Interferon-γ-release assay could have been useful here. Also, as in case 2, SACE levels could be high in some forms of pulmonary TB.5
Additionally, a common feature of all the four cases was the appearance of new lesions (cases 1 and 2) or worsening of existing lesions (cases 3 and 4) in the eye, after initiating ATT (Table 1). Such paradoxical reactions, also called Jarisch–Herxheimer reactions are an established phenomenon in patients with systemic TB,6, 7 and have also been described for ocular TB.2, 8 Suggested mechanisms include release of mycobacterial antigens after ATT, strengthening of host's immune response, and decrease in suppressor mechanisms.6 In cases 3 and 4, however, it may also be argued that inadequate anti-inflammatory therapy resulted in worsening of ocular lesions. Rifampicin has been shown to reduce the bio-availability of prednisolone by 66%.9 In all the four cases, these reactions resolved by adding/increasing corticosteroid therapy.
Tubercular uveitis therefore warrants a strong index of suspicion, and upon diagnosis, a combined anti-tubercular and anti-inflammatory therapy, for successful outcome.
References
Singh R, Gupta V, Gupta A . Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 2004; 52: 121–125.
Gupta V, Gupta A, Rao NA . Intra-ocular tuberculosis—an update. Surv Ophthalmol 2007; 52: 561–586.
Vasconcelos-Santos DV, Zierhut M, Rao NA . Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm 2009; 17: 351–355.
Holden M, Dubin MR, Diamond PH . Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971; 285: 1506–1509.
Brice EA, Friedlander W, Bateman ED, Kirsch RE . Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 1995; 107: 706–710.
Afghani B, Lieberman JM . Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994; 19: 1092–1099.
Cheng SL, Wang HC, Yang PC . Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2007; 11: 1290–1295.
Cheung CM, Chee SP . Jarisch-Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye 2009; 23: 1472–1473.
McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ . Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983; 286: 923–925.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Basu, S., Das, T. Pitfalls in the management of TB-associated uveitis. Eye 24, 1681–1684 (2010). https://doi.org/10.1038/eye.2010.110
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2010.110
Keywords
This article is cited by
-
The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area
International Ophthalmology (2021)
-
Neues zur Therapie der okulären Tuberkulose
Der Ophthalmologe (2020)
-
Paradoxical reactions in ocular tuberculosis
Journal of Ophthalmic Inflammation and Infection (2019)
-
Infectious uveitis: an Asian perspective
Eye (2019)
-
Reply to Wakefield and Kumar
Eye (2014)